NEW YORK (GenomeWeb News) – Febit today said that it has signed a strategic investment and technology development agreement with In-Q-Tel to further develop Febit’s Geniom technology for biosecurity applications.
The firms expect to improve the multiplex Geniom system for detection and classification of known and unknown pathogens.
“Febit’s partnership with In-Q-Tel enables us to focus on the field of pathogen detection, and further enhance an application-oriented device with well-defined requirements, similar to what we have developed in the field of microRNA analysis with the Geniom RT Analyzer,” Febit CEO Cord Staehler said in a statement.
In-Q-Tel is a non-profit investment firm created by the Central Intelligence Agency in 1999 with the goal of identifying and developing technology to support the mission of the US intelligence community.
Financial and other terms of the alliance were not disclosed.